Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.61 |
| ▸ | ATM | Q13315 | 1/20 | 0.61 |
| ▸ | NUDT1 | P36639 | 3/20 | 0.42 |
| ▸ | ADORA2A | P29274 | 3/20 | 0.42 |
| ▸ | WHR1 | P49842 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | PDE5A | O76074 | 3/20 | 0.39 |
| ▸ | ABCG2 | Q9UNQ0 | 3/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.38 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.37 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22113559 | 0.92 | MEN1 (0.52) | MEN1KMT2AATMNUDT1ADORA2A | |
| SCHEMBL22700339 | 0.92 | MEN1 (0.52) | MEN1KMT2AATMNUDT1ADORA2A | |
| SCHEMBL22113795 | 0.92 | MEN1 (0.52) | MEN1KMT2AATMNUDT1ADORA2A | |
| SCHEMBL22700368 | 0.91 | MEN1 (0.54) | MEN1KMT2AATMNUDT1ADORA2A | |
| SCHEMBL22113780 | 0.91 | MEN1 (0.53) | MEN1KMT2AATMNUDT1ADORA2A | |
| SCHEMBL22700296 | 0.91 | MEN1 (0.51) | MEN1KMT2AATMNUDT1ADORA2A | |
| SCHEMBL18314544 | 0.90 | MEN1 (0.48) | MEN1KMT2AATMNUDT1ADORA2A | |
| SCHEMBL22113707 | 0.90 | MEN1 (0.50) | MEN1KMT2AATMADORA2AWHR1 | |
| SCHEMBL22113778 | 0.89 | MEN1 (0.49) | MEN1KMT2AATMNUDT1ADORA2A | |
| SCHEMBL24741101 | 0.88 | MEN1 (0.49) | MEN1KMT2AATMNUDT1ADORA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11840538-B2 | Heterocyclic compounds and organic light emitting device using the same | LG CHEM, LTD. (KR) | 2023-12-12 | — | — | US | disclosed |
| US-20200190069-A1 | NOVEL HETEROCYCLIC COMPOUNDS AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | LG CHEM, LTD. (KR) | 2020-06-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11840538-B2 | Heterocyclic compounds and organic light emitting device using the same | CRY1, CYP1A1, CRY2 | MEN1 342/4885KMT2A 1637/4885ATM 3866/4885 |
| US-20200190069-A1 | NOVEL HETEROCYCLIC COMPOUNDS AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | CRY1, CRY2, CYP1A1 | MEN1 344/4885KMT2A 884/4885ATM 3654/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.